EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging

Fábio Fernando Alves da Silva iD, Sofia Nascimento Dos Santos, Lucas de Freitas Pedrosa, Vinicius Gonçalves Rodrigues, Jonathas Xavier Pereira, Jhonatas Pedrosa Marim Pereira, Dino Seigo Gushiken Junior, Thiécla Katiane Osvaldt Rosales, Luís Alberto Pereira Dias, Patrick Jack Spencer, João Paulo Fabi iD, Emerson Soares Bernardes iD

Biomacromolecules · 2026

DOI: 10.1021/acs.biomac.5c00915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Fábio Fernando Alves da Silva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Radiofarmácia, Comissão Nacional de Energia Nuclear, Instituto de Pesquisas Energéticas e Nucleares, São Paulo, São Paulo 05508-000, Brasil. Hauptthemen laut MEDLINE: Pectins, Molecular Imaging, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo, Center of Radiopharmacy at the Nuclear and Energy Research Institute (IPEN-CNEN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study employed molecular imaging to evaluate MCP (PectaSol-C, modified citrus pectin, a complex polysaccharide with antitumor potential) absorption and pharmacokinetics following oral and intravenous (IV) administration. MCP was radiolabeled with technetium-99m (99mTc) ([99mTc]MCP), allowing precise in vivo tracking. Imaging and biodistribution analyzes revealed low tumor uptake of IV [99mTc]MCP, with predominant renal and hepatobiliary clearance. Within tumors, MCP was detected at low levels and did not bind to viable cells. Consistent with these findings, IV administration produced only modest antitumor effects (∼50% tumor growth reduction) in SKOV-3 (ovarian), MKN45 (gastric), and 4T1 (breast) grafts, whereas oral administration was ineffective due to extremely poor absorption (bioavailability

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PectinsMolecular ImagingAntineoplastic AgentsAnimalsAdministration, OralMiceHumansFemaleTechnetiumAdministration, IntravenousTissue DistributionGalectin 3Cell Line, TumorMice, Knockout

Substanzen

Pectinscitrus pectinTechnetiumGalectin 3Antineoplastic Agents

Autor:innen und Institutionen

  • Centro de Radiofarmácia, Comissão Nacional de Energia Nuclear, Instituto de Pesquisas Energéticas e Nucleares, São Paulo, São Paulo 05508-000, Brasil.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, U.K.
  • Department of Food Science and Experimental Nutrition, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo 05508-900, Brazil.
  • Instituto de Patologia Tropical e Saúde Pública (IPTSP), Universidade Federal de Goiás (UFG), Goiânia, Goiás 74605-050, Brasil.
  • Centro de Biotecnologia, Comissão Nacional de Energia Nuclear, Instituto de Pesquisas Energéticas e Nucleares, São Paulo, São Paulo 05508-000, Brasil.

ORCID-Profile: Fábio Fernando Alves da Silva, João Paulo Fabi, Emerson Soares Bernardes

Förderung

  • Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
  • Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo
  • Center of Radiopharmacy at the Nuclear and Energy Research Institute (IPEN-CNEN)

Zitieren

APA

da Silva, F. F. A., Dos Santos, S. N., Pedrosa, L. F., Rodrigues, V. G., Pereira, J. X., Pereira, J. P. M., Gushiken Junior, D. S., Rosales, T. K. O., Dias, L. A. P., Spencer, P. J., Fabi, J. P., & Bernardes, E. S. (2026). Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00915

Vancouver

da Silva FFA, Dos Santos SN, Pedrosa LF, Rodrigues VG, Pereira JX, Pereira JPM, et al. Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c00915

BibTeX
@article{daSilva2026,
  author = {da Silva, Fábio Fernando Alves and Dos Santos, Sofia Nascimento and Pedrosa, Lucas de Freitas and Rodrigues, Vinicius Gonçalves and Pereira, Jonathas Xavier and Pereira, Jhonatas Pedrosa Marim and Gushiken Junior, Dino Seigo and Rosales, Thiécla Katiane Osvaldt and Dias, Luís Alberto Pereira and Spencer, Patrick Jack and Fabi, João Paulo and Bernardes, Emerson Soares},
  title = {Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging},
  journal = {Biomacromolecules},
  year = {2026},
  doi = {10.1021/acs.biomac.5c00915}
}
Kostenlos starten →